Journals / Turkish Journal of Gastroenterology / 2017 / Cilt: 28 - Sayı: 1

Functional bowel disorders and associated risk factors in hemodialysis patients in Turkey

Pages
12–19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FBDs are most frequently observed in females and housewives with high serum P levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Functional bowel disorders (FBDs) impair the quality of life in patients with end-stage renal disease (ESRD).
📊
Key Findings & Data:The aim of our study was to determine the prevalence and distribution of the subtypes of FBDs in hemodialysis (HD) patients.Materials and Methods: This prospective, cross-sectional study included 80 patients who received HD for more than 3 months (patient group) and 80 healthy controls (control group).
💡
Conclusion & Impact:FBDs are most frequently observed in females and housewives with high serum P levels.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Functional bowel disorders (FBDs) impair the quality of life in patients with end-stage renal disease (ESRD). The aim of our study was to determine the prevalence and distribution of the subtypes of FBDs in hemodialysis (HD) patients.Materials and Methods: This prospective, cross-sectional study included 80 patients who received HD for more than 3 months (patient group) and 80 healthy controls (control group). FBDs were diagnosed according to the Rome II diagnostic criteria by excluding organic pathologies.Results: Forty-six (57.5%) patients were males, and their average age was 62.13±12.92 (23-90) years. The mean duration of dialysis was 57.48±59.23 (3-312) months, and the mean Kt/V (K: dialyzer clearance of urea, t: dialysis time, V: volume of distrubition of urea) value was 1.53±0.31. The rate of FBDs was significantly higher in the patient group than in the control group (p=0.01). In total, 7.5% of the patients had irritable bowel syndrome, 3.8% had functional bloating, and 16.3% had functional constipation. FBDs were significantly higher in women (p=0.004). While there was no statistically significant difference between patients with and those without FBDs in terms of the presence of additional diseases, smoking, alcohol use, educational level, marital status, and residential areas (p>0.05), serum phosphorus (P) levels were significantly higher in the patients with FBDs (p=0.03).Conclusion: FBDs and their functional constipation subtype are more common in HD patients than in the healthy population in Turkey. FBDs are most frequently observed in females and housewives with high serum P levels.

🔖

Cite This Article

GÖK, E. G., İNCİ, A., ÇOBAN, M., ASLAN, D. K., KÜRŞAT, S. (2017). Functional bowel disorders and associated risk factors in hemodialysis patients in Turkey. Turkish Journal of Gastroenterology, Cilt: 28 - Sayı: 1, 12–19. https://ajindex.com/articles/410185

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Yasuda G, Shibata K, Takizawa T, et al. Prevalence of constipation in con- tinuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients. Am J Kidney Dis 2002; 39: 1292-9. [CrossRef] Hammer J, Oesterreicher C, Hammer K, Koch U, Traindl O, Kovarik J. Chronic gastrointestinal symptoms in hemodialysis patients. Wien Klin Wochenschr 1998; 110: 287-91.
  2. Abu Farsakh NA, Roweily D, Rababaa E, Butchoun R. Brief report:Evaluation of the upper gastrointestinal tract in uraemic patients undergoing haemodialysis. Nephrol Dial Transplant 1996; 11: 847-50. [CrossRef] Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4. [CrossRef] Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-90. [CrossRef] The American Gastroenterological Association Institute. J Gastro 2005; 11: 61. Kang JY. Systematic review: The influence of geography and eth- nicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 21: 663-76. [CrossRef] Kahvecioglu S, Akdag I, Kiyici M, et al. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in pa- tients with chronic renal failure. J Nephrol 2005; 18: 61-6.
  3. Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemio- logical survey of constipation in Canada: definitions, rates, demo- graphics and predictors of health care. Am J Gastroenterol 2001; 96: 3131-7. [CrossRef] Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabe- tes mellitus: A population-based survey of 15,000 adults. Arch Intern Med 2001; 161: 1989-96. [CrossRef] Cano AE, Neil AK, Kang JY, et al. Gastrointestinal symptoms in patients with end-Stage renal disease undergoing treatment by hemodialysis or peritoneal Dialysis. Am J Gastroenterol 2007; 102: 1990-7. [CrossRef] Shakil A, Church RJ, Rao SS. Gastrointestinal complications of dia- betes. Am Fam Physician 2008; 77: 1697-702. Daugirdas JT. Second generation logarithmic estimates of single- pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993; 4: 1205-13. Daurgidas JT. Chronic hemodialysis prescription: A urea kinetic approach. Handbook of dialysis'de. Eds.Daurgidas JT, Ings TS (2nd ed). Boston Little, Brown and Company, 1994: 92-120.
  4. Drossman DA, Corazziari E, Delvaux M, et al. Rome, The functional gastrointestinal disorders. McLean, VA: Degnon Associate